Opus Genetics is up a bit on the day, funds flowing in kept the price up 1.10% since yesterday.
The company isn't at an immediate support or resistance level that might be predictive. Opus Genetics hasn't established a very strong momentum in either direction over the last 3 months. We'll see if a stronger consensus among market participants emerges. IRD might find some support at the 1.93 level, buyers might push the price back up from here. But it's not very clear what will happen.